Patients, physicians, and others with a stake in nonalcoholic steatohepatitis (NASH) – a chronic condition caused by the buildup of fat and inflammation in the liver – convened for a roundtable to discuss a new survey sponsored by Intercept Pharmaceuticals, Inc. The NASH TRUTH (Time to Get Real About Liver Health) Survey examined the impact of communication barriers, knowledge gaps, and social stigma on patients with NASH and the healthcare providers who treat them.
In a series of video interviews, roundtable participants discuss the disease, how it has affected them, and what the future holds for those living with and treating NASH. You’ll also find more information on the survey, the disease, and ongoing clinical trials through the links below.
Hi Wayne, as always very interesting and informative post.
I have been reading up about AFLD STEATOHEPATITUS.
very similar symptoms but also confusing to me after i was told as you know that i have fatty liver on top of cirrhosis.. yet i haven't touched a drop of alcohol in a long time.
This is one thing that i need to get to the bottom of when i see my consultant 🤔. Cant be due to alcohol yet my diet is quite good apart from the old sweet tooth..
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.